Celldex Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Celldex Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Celldex Therapeutics Inc.
Rating: 1.86825
Author: Trendlyne DVM scores

about

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, a...

33.86 -0.01 (-0.03%)

Near 52W High of $34.52

853.2K

XNAS Volume

XNAS 16 Apr, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

4.0 / 100

Technically Bullish

70.7 / 100

1Yr Price target upside is 60%

15 analysts

Celldex Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celldex Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, a...

Near 52W High of $34.52

SWOT Analysis

Celldex Therapeutics Inc Live Price Chart